Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-24 @ 7:39 PM
NCT ID:
NCT02415803
Eligibility Criteria:
Inclusion Criteria:
* hospitalized for NSTE-ACS within the preceding 48 h
* have one of the following additional criteria:
1. ischemic symptoms at rest, lasting ≥10 minutes;
2. horizontal or down-sloping ST segment depression ≥0.1 mV;
3. cardiac troponin I (cTnI), marker associated with NSTE-ACS, local laboratory upper limit of normal values;
4. underwent percutaneous coronary intervention (PCI); (5) a history of myocardial infarction.
Exclusion Criteria:
* ST-elevation ACS;
* planned use of glycoprotein IIb/IIIa receptor inhibitors, adenosine diphosphate (ADP) receptor antagonists, or anticoagulant therapy during the study period;
* platelet count \<100g/L;
* creatinine clearance rate \< 30ml/min;
* diagnosed as respiratory or circulatory instability (cardiac shock, severe congestive heart failure NYHA II-IV or left ventricular ejection fraction \< 40%);
* a history of bleeding tendency;
* aspirin, ticagrelor or clopidogrel allergies;
* diabetes.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02415803
Study Brief:
Protocol Section:
NCT02415803